Industrial Purity Specifications for Methyl 3-Fluorobenzoate in API Synthesis
- Assay standards typically exceed 99.0% for pharmaceutical intermediates.
- Strict moisture control (≤0.2%) is critical for downstream reaction yields.
- Bulk procurement significantly reduces unit costs compared to laboratory packs.
In the realm of fine chemical manufacturing and pharmaceutical intermediate production, the specification sheet is not merely a document; it is a guarantee of reaction efficiency. Methyl 3-Fluorobenzoate (CAS: 455-68-5) serves as a critical building block in the synthesis of various agrochemicals and active pharmaceutical ingredients (APIs). For process chemists and procurement managers, understanding the nuances of industrial purity is essential to prevent downstream contamination and ensure consistent batch-to-batch performance.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to rigorous quality control protocols that exceed standard market expectations. This technical overview details the physical properties, impurity profiles, and commercial considerations necessary for sourcing this fluorinated ester at an industrial scale.
Physical and Chemical Specifications
Accurate physical data is fundamental for process design, particularly regarding distillation parameters and storage conditions. The following table outlines the critical physical properties required for quality assurance during incoming goods inspection.
| Property | Specification Standard |
|---|---|
| CAS Number | 455-68-5 |
| Molecular Formula | C8H7FO2 |
| Molecular Weight | 154.14 g/mol |
| Appearance | Colorless to light yellow liquid |
| Assay (Purity) | ≥ 99.0% (GC Area %) |
| Boiling Point | 194-195 °C |
| Density | 1.171 ± 0.06 g/cm³ |
| Water Content | ≤ 0.2% (Karl Fischer) |
| HS Code | 2916310090 |
Maintaining the density within the specified range of 1.171 g/cm³ is often a quick initial check for gross contamination. However, gas chromatography (GC) remains the definitive method for verifying the assay. Deviations in the boiling point can indicate the presence of unreacted starting materials or higher boiling esters, which may complicate purification steps in subsequent synthetic stages.
Critical Impurity Profiles and Moisture Control
The manufacturing process for 3-Fluorobenzoic Acid Methyl Ester typically involves the esterification of 3-fluorobenzoic acid with methanol. While this synthesis route is well-established, specific impurities must be monitored. The primary concern is the presence of residual acids, which can catalyze unwanted side reactions in sensitive downstream couplings.
Furthermore, moisture control is paramount. Water content exceeding 0.2% can hydrolyze the ester back to the acid during storage or interfere with moisture-sensitive reagents such as organolithiums or Grignard reagents used in later functionalization steps. Industrial-grade specifications demand rigorous drying protocols, often involving molecular sieves or vacuum distillation immediately prior to drumming.
When sourcing high-purity Methyl 3-Fluorobenzoate, buyers should insist on a comprehensive Certificate of Analysis (COA) that explicitly lists water content and related substances. A robust COA provides traceability and confirms that the batch meets the stringent requirements for API synthesis.
Commercial Viability and Bulk Procurement
Market analysis indicates significant price volatility between laboratory-scale packs and industrial quantities. Small packaging (e.g., 5g to 100g) often carries a premium price per kilogram due to handling and packaging costs. In contrast, bulk procurement in drum or IBC quantities offers a substantially lower bulk price, optimizing the cost of goods sold (COGS) for large-scale production.
Procurement strategies should focus on long-term supply agreements to mitigate market fluctuations. As a leading entity in the chemical sector, NINGBO INNO PHARMCHEM CO.,LTD. ensures stable supply chains and consistent quality, reducing the risk of production stoppages due to material shortages.
Storage and Safety Considerations
Proper storage is essential to maintain industrial purity over time. The product should be kept in sealed containers at room temperature, away from strong oxidizing agents and bases. According to safety data, the compound carries a GHS07 warning signal.
- Hazard Statements: H302 (Harmful if swallowed), H315 (Causes skin irritation), H319 (Causes serious eye irritation), H335 (May cause respiratory irritation).
- Precautionary Statements: P261 (Avoid breathing dust/fume/gas/mist/vapors/spray), P305+P351+P338 (IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing).
- Storage Class: Combustible acute toxic Cat.3 toxic compounds.
Adherence to these safety guidelines ensures not only regulatory compliance but also the preservation of product integrity. Exposure to humidity or incompatible chemicals can degrade the quality of the ester, rendering it unsuitable for high-value pharmaceutical applications.
Conclusion
Securing a reliable supply of fluorinated intermediates requires a partner who understands both the chemical nuances and the commercial demands of the pharmaceutical industry. By prioritizing assay standards, moisture control, and verified documentation, manufacturers can safeguard their production yields. For enterprises seeking a dependable source of high-quality intermediates, partnering with an experienced supplier ensures that every batch meets the exacting standards required for modern drug development.